1. Known history of ivermectin allergy <br/ >2. Hypersensitivity to any component of ivermectin <br/ >3. Refusal of consent (Appendix 5 and 6). <br/ >4. Co-morbidities e.g. Acute or chronic renal disease , History of coronary disease , pregnancy, History of cerebrovascular disease and malignancy <br/ >5. Current use of CYP 3A4 or P-gp inhibitor drugs such as quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir or cobicistat. Concomitant use of critical CYP3A4 substrate drugs such as warfarin. <br/ >6.Prior use of ivermectin in last 15 days <br/ >

1. Known history of ivermectin allergy <br/ >2. Hypersensitivity to any component of ivermectin <br/ >3. Refusal of consent (Appendix 5 and 6). <br/ >4. Co-morbidities e.g. Acute or chronic renal disease , History of coronary disease , pregnancy, History of cerebrovascular disease and malignancy <br/ >5. Current use of CYP 3A4 or P-gp inhibitor drugs such as quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir or cobicistat. Concomitant use of critical CYP3A4 substrate drugs such as warfarin. <br/ >6.Prior use of ivermectin in last 15 days <br/ >

N/A

N/A

1. Known history of ivermectin allergy <br/ >2. Hypersensitivity to any component of ivermectin <br/ >3. Refusal of consent (Appendix 5 and 6). <br/ >4. Co-morbidities e.g. Acute or chronic renal disease , History of coronary disease , pregnancy, History of cerebrovascular disease and malignancy <br/ >5. Current use of CYP 3A4 or P-gp inhibitor drugs such as quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir or cobicistat. Concomitant use of critical CYP3A4 substrate drugs such as warfarin. <br/ >6.Prior use of ivermectin in last 15 days <br/ >

1. Known history of ivermectin allergy <br/ >2. Hypersensitivity to any component of ivermectin <br/ >3. Refusal of consent (Appendix 5 and 6). <br/ >4. Co-morbidities e.g. Acute or chronic renal disease , History of coronary disease , pregnancy, History of cerebrovascular disease and malignancy <br/ >5. Current use of CYP 3A4 or P-gp inhibitor drugs such as quinidine, amiodarone, diltiazem, spironolactone, verapamil, clarithromycin, erythromycin, itraconazole, ketoconazole, cyclosporine, tacrolimus, indinavir, ritonavir or cobicistat. Concomitant use of critical CYP3A4 substrate drugs such as warfarin. <br/ >6.Prior use of ivermectin in last 15 days <br/ >